Eagle Pharmaceuticals, Inc. to Present at Jefferies 2017 London Healthcare Conference

WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)-- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or “the Company”) today announced that Scott Tarriff, Chief Executive Officer, will present at the Jefferies 2017 London Healthcare Conferences as follows:

The presentation will be webcast live at the aforementioned time, and archived for 30 days thereafter, via the Company’s website at www.eagleus.com, under the Investors Section.

About Eagle Pharmaceuticals, Inc.

Eagle is a specialty pharmaceutical company focused on developing and commercializing injectable products that address the shortcomings, as identified by physicians, pharmacists and other stakeholders, of existing commercially successful injectable products. Eagle’s strategy is to utilize the FDA's 505(b)(2) regulatory pathway. Additional information is available on the Company’s website at www.eagleus.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20171107006673/en/

Investor Relations for Eagle Pharmaceuticals, Inc:
Lisa M. Wilson, 212-452-2793
[email protected]

Source: Eagle Pharmaceuticals, Inc.

You May Also Be Interested In

• George Mason University Partners With Oxford-Based TreQ to Bring the First Open-Architecture Quantum Computing System to Virginia
• Nokia's Sustainability Strategy: An Engine for Innovation, Collaboration, and Long-Term Impact
• Stardust Enters Quebec as Hydro-Quebec Incentive Enhances Solar Market Opportunity